Elanco Animal Health IncorporatedELANNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank80
5Y CAGR-22.3%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

5Y CAGR
-22.3%/yr
Long-term compound
Percentile
P80
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
20258.83%
20242.26%
20231.58%
2022-9.84%
202140.78%
202031.10%
20193.40%
2018-5.72%
2017-0.64%
2016-14.32%